Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1965.5%
Neutral931.0%
Bearish13.5%
FN2 Earnings Intelligence
Arthur J. Gallagher & Co. (AJG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Neutral | Upgrade | Jul 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 11, 2026 |
| Citigroup | Buy | Neutral | Upgrade | May 6, 2026 |
| Truist Securities | Hold | Hold | Maintain | May 1, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Mar 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Dec 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 31, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Oct 10, 2024 |
| TD Cowen | Hold | Hold | Maintain | Aug 13, 2024 |
| Argus Research | Buy | Buy | Maintain | May 14, 2024 |
| Raymond James | Market Perform | Strong Buy | Downgrade | Dec 12, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | May 18, 2021 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jan 11, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jun 18, 2020 |
| CFRA | Hold | Hold | Maintain | May 20, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Aug 1, 2016 |
| William Blair | Market Perform | Underweight | Upgrade | Mar 21, 2016 |
| Sandler O'Neill | Buy | Hold | Upgrade | Apr 10, 2014 |
| Compass Point | Buy | Neutral | Upgrade | Apr 2, 2014 |
| Macquarie | Outperform | Neutral | Upgrade | Jan 28, 2014 |
| Bank of America | Buy | Neutral | Upgrade | Jan 31, 2013 |
Upside is calculated against the persisted current price $267.26. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $276 | $253.83 | +3.3% | Jul 15, 2026 |
| RBC Capital | Rowland Mayor | $300 | $256.39 | +12.3% | Jul 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $253 | +12.3% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $287 | $256.61 | +7.4% | Jul 9, 2026 |
| UBS | Brian Meredith | $291 | $253.52 | +8.9% | Jul 8, 2026 |
| Barclays | Alex Scott | $292 | $249.77 | +9.3% | Jul 7, 2026 |
| Morgan Stanley | Bob Huang | $255 | $252.44 | -4.6% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $265 | $220.14 | -0.8% | Jun 11, 2026 |
| UBS | Analyst unavailable | $250 | $212.52 | -6.5% | Jun 8, 2026 |
| UBS | Analyst unavailable | $240 | $203.61 | -10.2% | May 21, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $202.19 | -0.8% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $225 | $216.1 | -15.8% | May 1, 2026 |
| Piper Sandler | Paul Newsome | $211 | $206.4 | -21.1% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $259 | $219.12 | -3.1% | Apr 13, 2026 |
| Piper Sandler | Analyst unavailable | $226 | $216.51 | -15.4% | Feb 23, 2026 |
| UBS | Analyst unavailable | $283 | $249.37 | +5.9% | Feb 2, 2026 |
| Truist Financial | Analyst unavailable | $271 | $250.75 | +1.4% | Jan 30, 2026 |
| Piper Sandler | Paul Newsome | $249 | $245.84 | -6.8% | Jan 30, 2026 |
| Wells Fargo | Analyst unavailable | $298 | $245.84 | +11.5% | Jan 30, 2026 |
| Mizuho Securities | Yaron Kinar | $277 | $257 | +3.6% | Jan 14, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $282 | $257 | +5.5% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $311 | $264.84 | +16.4% | Jan 13, 2026 |
| BMO Capital | Michael Zaremski | $275 | $264.84 | +2.9% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $247 | $259 | -7.6% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $292 | $259 | +9.3% | Jan 7, 2026 |
| Piper Sandler | Analyst unavailable | $272 | $262.77 | +1.8% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $328 | $253.39 | +22.7% | Dec 22, 2025 |
| Morgan Stanley | Analyst unavailable | $300 | $252.64 | +12.3% | Dec 19, 2025 |
| Needham | Analyst unavailable | $272 | $251.52 | +1.8% | Dec 18, 2025 |
| UBS | Brian Meredith | $285 | $251.98 | +6.6% | Dec 17, 2025 |
| Goldman Sachs | Analyst unavailable | $293 | $252.12 | +9.6% | Dec 17, 2025 |
| Wolfe Research | Tracy Benguigui | $289 | $251.98 | +8.1% | Dec 17, 2025 |
| Evercore ISI | David Motemaden | $334 | $251.98 | +25.0% | Dec 17, 2025 |
| Truist Financial | Analyst unavailable | $280 | $251.38 | +4.8% | Dec 16, 2025 |
| Mizuho Securities | Yaron Kinar | $276 | $256.19 | +3.3% | Dec 15, 2025 |
| Piper Sandler | Analyst unavailable | $280 | $255.46 | +4.8% | Dec 15, 2025 |
| Wells Fargo | Elyse Greenspan | $344 | $245.41 | +28.7% | Dec 5, 2025 |
| Barclays | Analyst unavailable | $250 | $248.72 | -6.5% | Nov 20, 2025 |
| Piper Sandler | Paul Newsome | $295 | $246.23 | +10.4% | Oct 31, 2025 |
| Goldman Sachs | Robert Cox | $315 | $244.82 | +17.9% | Oct 31, 2025 |
| Evercore ISI | David Motemaden | $353 | $262.03 | +32.1% | Oct 31, 2025 |
| Piper Sandler | Paul Newsome | $340 | $305.84 | +27.2% | Oct 2, 2025 |
| UBS | Analyst unavailable | $329 | $297.91 | +23.1% | Sep 19, 2025 |
| Wells Fargo | Analyst unavailable | $365 | $297.91 | +36.6% | Sep 19, 2025 |
| Truist Financial | Mark Hughes | $290 | $301.82 | +8.5% | Jan 31, 2025 |
| Goldman Sachs | Robert Cox | $313 | $304.29 | +17.1% | Nov 25, 2024 |
| BMO Capital | Michael Zaremski | $325 | $281.45 | +21.6% | Nov 12, 2024 |
| Bank of America Securities | Joshua Shanker | $293 | $294.94 | +9.6% | Oct 10, 2024 |
| Jefferies | Yaron Kinar | $274 | $293.16 | +2.5% | Oct 9, 2024 |
| Goldman Sachs | Robert Cox | $300 | $279.45 | +12.3% | Sep 27, 2024 |
| RBC Capital | Scott Heleniak | $320 | $282.2 | +19.7% | Sep 20, 2024 |
| Barclays | Alex Scott | $300 | $297.75 | +12.3% | Sep 4, 2024 |
| CFRA | Catherine Seifert | $320 | $283.58 | +19.7% | Jul 26, 2024 |
| Truist Financial | Mark Hughes | $265 | $282.14 | -0.8% | Jul 26, 2024 |
| RBC Capital | Scott Heleniak | $310 | $280.9 | +16.0% | Jul 26, 2024 |
| Piper Sandler | Paul Newsome | $254 | $273.97 | -5.0% | Jul 26, 2024 |
| RBC Capital | Scott Heleniak | $290 | $254.52 | +8.5% | Jun 26, 2024 |
| Argus Research | John Staszak | $270 | $249.5 | +1.0% | May 14, 2024 |
| Piper Sandler | Paul Newsome | $252 | $234.21 | -5.7% | Apr 29, 2024 |
| Truist Financial | Mark Hughes | $255 | $244.13 | -4.6% | Apr 10, 2024 |
| Citigroup | Analyst unavailable | $228 | $196.32 | -14.7% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $215 | $190.17 | -19.6% | Dec 29, 2022 |
| Citigroup | Analyst unavailable | $225 | $193.11 | -15.8% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $204 | $196.28 | -23.7% | Nov 22, 2022 |
| Jefferies | Yaron Kinar | $211 | $158.74 | -21.1% | Jun 23, 2022 |
| Raymond James | Analyst unavailable | $195 | $168.49 | -27.0% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $211 | $179.33 | -21.1% | Apr 29, 2022 |
| UBS | Weston Bloomer | $192 | $179.5 | -28.2% | Apr 20, 2022 |
| Truist Financial | Mark Hughes | $205 | $183.22 | -23.3% | Apr 11, 2022 |
| Bank of America Securities | Joshua Shanker | $151 | $166.64 | -43.5% | Oct 29, 2021 |
| Deutsche Bank | Phil Stefano | $145 | $137.99 | -45.7% | Jul 30, 2021 |
Track every rating change on AJG the moment it posts. Free to start.
Start free